Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07110285

Ovarian Stimulation Outcomes During a GnRH Antagonist Protocol for In-vitro Fertilization When Comparing Trigger Day Decision by Physicians Versus an Artificial Intelligence-based Algorithm.

Ovarian Stimulation Outcomes During a GnRH Antagonist Protocol for In-vitro Fertilization When Comparing Trigger Day Decision by Physicians Versus an Artificial Intelligence-based Algorithm - A Randomized Control Study.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
180 (estimated)
Sponsor
FertilAI · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

To compare the number of mature oocytes following a GnRH antagonist in-vitro fertilization stimulation cycle when comparing trigger day timing decision by physicians versus an artificial intelligence-based algorithm

Detailed description

Examination of all patients undergoing an ovarian stimulation cycle utilizing the GnRH antagonist protocol for oocyte cryopreservation or for fertilization via intracytoplasmic sperm injection (ICSI) (any treatment where oocytes are denuded and maturity may be assessed). The number of mature oocytes will be compared between cycles where trigger day timing was decided by the treating physician versus an artificial intelligence-based algorithm.

Conditions

Interventions

TypeNameDescription
OTHERArtificial intelligence-based algorithmTrigger day timing decision by an artificial intelligence-based algorithm

Timeline

Start date
2025-05-21
Primary completion
2027-05-01
Completion
2028-05-21
First posted
2025-08-07
Last updated
2026-01-12

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT07110285. Inclusion in this directory is not an endorsement.